A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ...
Scientists have found evidence in mice and human brain tissue that the drug ponesimod can reduce inflammation and toxic amyloid plaques common in Alzheimer's. Reading time 2 minutes An existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results